{"id":8087,"date":"2024-03-19T13:11:11","date_gmt":"2024-03-19T13:11:11","guid":{"rendered":"https:\/\/www.optima-oncology.eu\/salidas\/"},"modified":"2024-11-22T16:46:41","modified_gmt":"2024-11-22T16:46:41","slug":"salidas-optima-en-pocas-palabras","status":"publish","type":"page","link":"https:\/\/www.optima-oncology.eu\/es\/salidas-optima-en-pocas-palabras\/","title":{"rendered":"Salidas &#8211;  OPTIMA en pocas palabras"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbHeader  \u00bb module_id=\u00bbsection001bgs\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb background_image=\u00bbhttps:\/\/www.optima-oncology.eu\/wp-content\/uploads\/bg-ellipse-wp-section-001.svg\u00bb background_size=\u00bbinitial\u00bb background_position=\u00bbcenter_left\u00bb min_height=\u00bb440px\u00bb min_height_tablet=\u00bb355px\u00bb min_height_phone=\u00bb\u00bb min_height_last_edited=\u00bbon|tablet\u00bb height=\u00bb440px\u00bb height_tablet=\u00bb355px\u00bb height_phone=\u00bb\u00bb height_last_edited=\u00bbon|tablet\u00bb max_height_tablet=\u00bb355px\u00bb max_height_phone=\u00bb\u00bb max_height_last_edited=\u00bbon|tablet\u00bb custom_padding=\u00bb||12px|||\u00bb da_popup_slug=\u00bbsection001bgs\u00bb da_disable_devices=\u00bboff|off|off\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb da_is_popup=\u00bboff\u00bb da_exit_intent=\u00bboff\u00bb da_has_close=\u00bbon\u00bb da_alt_close=\u00bboff\u00bb da_dark_close=\u00bboff\u00bb da_not_modal=\u00bbon\u00bb da_is_singular=\u00bboff\u00bb da_with_loader=\u00bboff\u00bb da_has_shadow=\u00bbon\u00bb][et_pb_row _builder_version=\u00bb4.16&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb70%\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text module_class=\u00bbh1bug\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bb|800|||||||\u00bb header_font_size=\u00bb58px\u00bb header_line_height=\u00bb1.2em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb28px||||false|false\u00bb header_font_size_tablet=\u00bb24px\u00bb header_font_size_phone=\u00bb\u00bb header_font_size_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>Resultados<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbIntegration Factsheets &#038; Overview\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||101px|||\u00bb da_disable_devices=\u00bboff|off|off\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb da_is_popup=\u00bboff\u00bb da_exit_intent=\u00bboff\u00bb da_has_close=\u00bbon\u00bb da_alt_close=\u00bboff\u00bb da_dark_close=\u00bboff\u00bb da_not_modal=\u00bbon\u00bb da_is_singular=\u00bboff\u00bb da_with_loader=\u00bboff\u00bb da_has_shadow=\u00bbon\u00bb][et_pb_row _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_2_font=\u00bb|700|||||||\u00bb header_2_text_align=\u00bbcenter\u00bb header_2_line_height=\u00bb120%\u00bb header_4_line_height=\u00bb1.3em\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>OPTIMA en pocas palabras<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.16&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb70%\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb32px\u00bb text_line_height=\u00bb48px\u00bb header_text_align=\u00bbcenter\u00bb header_2_text_align=\u00bbleft\u00bb custom_padding=\u00bb0px||||false|false\u00bb text_font_size_tablet=\u00bb16px\u00bb text_font_size_phone=\u00bb\u00bb text_font_size_last_edited=\u00bbon|tablet\u00bb text_line_height_tablet=\u00bb24px\u00bb text_line_height_phone=\u00bb\u00bb text_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>\u00bfQuieres saber m\u00e1s sobre OPTIMA? Obt\u00e9n informaci\u00f3n breve pero concisa en nuestra <a title=\"Ficha informativa: OPTIMA de un vistazo\" href=\"https:\/\/www.optima-oncology.eu\/es\/resultados-optima-de-un-vistazo-revolucionando-la-oncologia\/\">hoja informativa &#8211; OPTIMA de un vistazo<\/a>, que presenta toda la informaci\u00f3n clave, o consulta con detalle nuestros documentos resumen, preparados para el p\u00fablico experto (<a title=\"Visi\u00f3n general \u2013 Principios y objetivos clave\" href=\"https:\/\/www.optima-oncology.eu\/es\/resultados-hojas-informativas-y-descripcion-general\/\">Resumen &#8211; Principios y objetivos clave<\/a>) y en lenguaje com\u00fan, dirigidos a los pacientes (<a title=\"Visi\u00f3n general - para pacientes\" href=\"https:\/\/www.optima-oncology.eu\/es\/resultados-vision-general-para-pacientes\/\">Resumen &#8211; para pacientes<\/a>) o para saber m\u00e1s sobre el uso de la Inteligencia Artificial (IA) en OPTIMA (<a title=\"IA Explicaci\u00f3n\" href=\"https:\/\/www.optima-oncology.eu\/es\/resultados-explicacion-de-la-inteligencia-artificial-ia\/\">IA Explicaci\u00f3n<\/a>).<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbVideo Library\u00bb _builder_version=\u00bb4.23.1&#8243; custom_padding=\u00bb0px|||||\u00bb bottom_divider_color=\u00bb#2B318A\u00bb da_disable_devices=\u00bboff|off|off\u00bb saved_tabs=\u00bball\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb da_is_popup=\u00bboff\u00bb da_exit_intent=\u00bboff\u00bb da_has_close=\u00bbon\u00bb da_alt_close=\u00bboff\u00bb da_dark_close=\u00bboff\u00bb da_not_modal=\u00bbon\u00bb da_is_singular=\u00bboff\u00bb da_with_loader=\u00bboff\u00bb da_has_shadow=\u00bbon\u00bb][et_pb_row _builder_version=\u00bb4.16&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_2_font=\u00bb|700|||||||\u00bb header_2_text_align=\u00bbcenter\u00bb header_2_line_height=\u00bb120%\u00bb header_4_line_height=\u00bb1.3em\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Videoteca<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbOPTIMA oncology project introduction\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Introducci\u00f3n al proyecto oncol\u00f3gico OPTIMA<\/h3>\n<p>OPTIMA (Tratamiento \u00f3ptimo para pacientes con tumores s\u00f3lidos en Europa a trav\u00e9s de la inteligencia artificial) es un programa de investigaci\u00f3n p\u00fablico-privado de 21,3 millones de euros que buscar\u00e1 utilizar la inteligencia artificial (IA) para mejorar la atenci\u00f3n a los pacientes con c\u00e1ncer de pr\u00f3stata, mama y pulm\u00f3n. <\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=XraTLcnuL-s&#038;t=7s\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbThe Public &#8211; Patient Advisory Board\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>El Consejo Asesor P\u00fablico\/Paciente<\/h3>\n<p>El objetivo final de OPTIMA es encontrar mejores y m\u00e1s personalizadas opciones de tratamiento para los pacientes y garantizar que tengan una buena calidad de vida. Escuche a cuatro miembros de la Junta Asesora P\u00fablica\/Paciente de OPTIMA sobre su participaci\u00f3n en organizaciones de defensa de pacientes, sus experiencias con el c\u00e1ncer y sus esperanzas para futuros pacientes.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/G2Q01dvhKqs\u00bb _builder_version=\u00bb4.22.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbConchi Biurrun\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Conchi Biurrun, Spanish Breast Cancer Federation of Associations<\/h3>\n<p>Conchi Biurrun, de la Federaci\u00f3n Espa\u00f1ola de Asociaciones de C\u00e1ncer de Mama y miembro del Consejo Asesor P\u00fablico\/Paciente de OPTIMA, habla de su trayectoria como paciente con c\u00e1ncer de mama, de su implicaci\u00f3n en el proyecto OPTIMA y de su esperanza de que este proyecto conduzca a mejores opciones de tratamiento m\u00e1s personalizadas y a una mejor calidad de vida para las pacientes.[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/dbFVoDFDu08&#8243; _builder_version=\u00bb4.22.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbErik Briers\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Erik Briers, European Prostate Cancer Coalition<\/h3>\n<p>Erik Briers, de la Coalici\u00f3n Europea contra el C\u00e1ncer de Pr\u00f3stata y miembro del Consejo Asesor de Pacientes y P\u00fablico de OPTIMA, habla sobre su experiencia con el c\u00e1ncer y c\u00f3mo un proyecto como OPTIMA puede ayudar a otros pacientes a recibir un tratamiento \u00f3ptimo con la ayuda de pruebas y directrices de la vida real.[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/bMP0nqXjP0o\u00bb _builder_version=\u00bb4.22.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbSeamus Cotter\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Seamus Cotter, Irish Lung Cancer Community<\/h3>\n<p>Escuche a Seamus Cotter, de la Comunidad Irlandesa de C\u00e1ncer de Pulm\u00f3n y miembro del Consejo Asesor P\u00fablico y de Pacientes de OPTIMA, sobre sus experiencias con los ensayos cl\u00ednicos y la importancia de proporcionar informaci\u00f3n clara sobre tratamientos espec\u00edficos a los pacientes para que tomen una decisi\u00f3n informada.[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/48FCpuKDDqM\u00bb _builder_version=\u00bb4.22.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbMarjo Forsblom\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Marjo Forsblom, Lung Cancer Europe<\/h3>\n<p>Marjo Forsblom, de Lung Cancer Europe, fue miembro del Consejo Asesor P\u00fablico\/Paciente de OPTIMA. En este video, explic\u00f3 c\u00f3mo OPTIMA har\u00e1 un buen uso de los datos de salud y tiene como objetivo desarrollar una herramienta que sepa qu\u00e9 es lo mejor para un paciente en una situaci\u00f3n espec\u00edfica. Lamentablemente, falleci\u00f3 en octubre de 2023. Con la bendici\u00f3n de su familia, decidimos mantener su video aqu\u00ed. Sus amigos y colegas de OPTIMA la echar\u00e1n mucho de menos.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/Iu0Qzt9VMOg\u00bb _builder_version=\u00bb4.22.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbNadia Harbeck\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Nadia Harbeck, LMU<\/h3>\n<h4>Aprender de datos bien protegidos del mundo real para encontrar las mejores terapias<\/h4>\n<p>Escuche a la Dra. Nadia Harbeck, directora del Hospital Universitario Breast Center LMU en M\u00fanich, explicando sobre big data, evidencia del mundo real e inteligencia artificial en el contexto del tratamiento y la investigaci\u00f3n del c\u00e1ncer de mama como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=lwW-gR0Cg94&#8243; _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbTorsten Blum, Helios\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Torsten Blum, Helios<\/h3>\n<h4>La importancia de compartir los datos cl\u00ednicos para una plataforma OPTIMA de gran valor &#8211; Torsten Blum<\/h4>\n<p>El Dr. Torsten Gerriet Blum, m\u00e9dico s\u00e9nior y neum\u00f3logo de Helios Klinikum, explica la importancia del intercambio de datos, el big data, la evidencia del mundo real y la inteligencia artificial en el contexto del tratamiento y la investigaci\u00f3n del c\u00e1ncer de pulm\u00f3n como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=QSLjx8pAEfA\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbMichael Bussmann, Helmholtz\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Michael Bussmann, Helmholtz<\/h3>\n<h4>Uso de la Inteligencia Artificial para transformar los datos en conocimiento<\/h4>\n<p>El Dr. Michael Bussmann, director fundador de CASUS ((por sus siglas en ingl\u00e9s) (Centro para la comprensi\u00f3n de sistemas avanzados) lidera el paquete de trabajo sobre la implementaci\u00f3n de la base de conocimientos de Inteligencia Artificial dentro de OPTIMA. En este v\u00eddeo, aprende m\u00e1s sobre c\u00f3mo la inteligencia artificial puede aportar valor a\u00f1adido en el contexto de la atenci\u00f3n oncol\u00f3gica como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=wPSYXv8pyRA\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbNicolas Mottet, EAU\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Nicolas Mottet, EAU<\/h3>\n<h4>Mejorar las pautas a trav\u00e9s de datos del mundo real para un mejor tratamiento<\/h4>\n<p>El Prof. Dr. Nicolas Mottet es Jefe del Departamento de Urolog\u00eda del Centro Hospitalario Universitario de Saint-Etienne y Presidente de la EAU. El Profesor explica c\u00f3mo mejorar las directrices a trav\u00e9s de datos del mundo real para un mejor tratamiento en el contexto del tratamiento y la investigaci\u00f3n del c\u00e1ncer de pr\u00f3stata como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=xOy7oCTKxs8&#8243; _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbAndreas Kremer &#038; Bertrand De Meulder\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Andreas Kremer y Bertrand De Meulder<\/h3>\n<h4>Hacer que la plataforma OPTIMA sea m\u00e1s \u00fatil para todas las partes interesadas<\/h4>\n<p>El Dr. Andreas Kremer y el Dr. Bertrand De Meulder lideran las tareas de an\u00e1lisis de los requisitos de la plataforma y la implementaci\u00f3n y evaluaci\u00f3n de la misma. En este v\u00eddeo, se puede obtener m\u00e1s informaci\u00f3n sobre los planes de la plataforma OPTIMA y sobre el papel de la inteligencia artificial en el contexto de la atenci\u00f3n sanitaria como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=Tnp2CK6_Vvc\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbDr. Pippa Powell\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Dra. Pippa Powell<\/h3>\n<h4>La participaci\u00f3n del Consejo Asesor de Pacientes y P\u00fablico de OPTIMA<\/h4>\n<p>La Dra. Pippa Powell, directora de la Fundaci\u00f3n Europea del Pulm\u00f3n, crean el v\u00ednculo entre los pacientes y las organizaciones de pacientes, y la investigaci\u00f3n enfatiza en este v\u00eddeo la importancia de la participaci\u00f3n de los pacientes en el proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=wz6A0KakFWk\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbPeter-Paul Willemse\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Peter-Paul Willemse, OPTIMA<\/h3>\n<h4>Compartir big data y evidencia del mundo real para resolver preguntas cl\u00ednicas<\/h4>\n<p>El Dr. Peter-Paul Willemse es profesor asistente y doctor en medicina en el Departamento de Oncolog\u00eda Urol\u00f3gica de UMC Utrecht. En OPTIMA, representa a la comunidad cl\u00ednica que trata a pacientes con c\u00e1ncer de pr\u00f3stata y explica c\u00f3mo el intercambio de big data y evidencia del mundo real puede ayudar a resolver preguntas cl\u00ednicas como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=yaqJsdpLDP0&#8243; _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbProf. Daniel Prieto Alhambra\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Prof. Daniel Prieto Alhambra<\/h3>\n<h4>Big Data en el contexto de la salud<\/h4>\n<p>Daniel Prieto Alhambra es catedr\u00e1tico de Epidemiolog\u00eda de Farmaco y Dispositivos y lidera el paquete de trabajo sobre datos de estudios (no) intervencionistas y recopilaci\u00f3n de datos del mundo real dentro de OPTIMA. En este v\u00eddeo, analiza el papel del big data en el contexto de la atenci\u00f3n sanitaria como parte del proyecto OPTIMA.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=qf-hG2E0fBM\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbM. Roobol\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>Monique Roobol<\/h3>\n<h4>Transformaci\u00f3n de las pautas en herramientas electr\u00f3nicas de toma de decisiones para pacientes individuales<\/h4>\n<p>Monique Roobol es catedr\u00e1tica de Toma de Decisiones en Urolog\u00eda y aqu\u00ed explica el proyecto OPTIMA y por qu\u00e9 es importante que el proyecto convierta las pautas cl\u00ednicas en herramientas electr\u00f3nicas de apoyo a la toma de decisiones.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=bwrO8GOUfdg\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbJames N&#8217;Dow and Hagen Kr\u00fcger\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>James N&#8217;Dow y Hagen Kr\u00fcger<\/h3>\n<h4>Uniendo fuerzas en una Asociaci\u00f3n P\u00fablico Privada para encontrar mejores tratamientos para pacientes oncol\u00f3gicos<\/h4>\n<p>El Prof. Dr. James N&#8217; Dow, Coordinador Acad\u00e9mico y Secretario General Adjunto de la EAU y el Dr. Hagen Kr\u00fcger, Director M\u00e9dico Senior de Pfizer coordinan juntos el proyecto OPTIMA. Aqu\u00ed, dan una visi\u00f3n general del proyecto y hablan de la importancia de la colaboraci\u00f3n entre los socios p\u00fablicos y privados en el marco del IMI.<\/p>\n<p>&nbsp;[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; Do not Remove\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=6dPnsVgTvkM\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbLegal and ethical aspects\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb header_2_line_height=\u00bb1.3em\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Los fascinantes aspectos legales y \u00e9ticos de OPTIMA<\/h2>\n<p>\u00bfTienes curiosidad sobre los aspectos legales y \u00e9ticos de OPTIMA? Presentamos nuestro paquete de trabajo 2, que se centra en la investigaci\u00f3n sobre la protecci\u00f3n de datos y el marco jur\u00eddico emergente en torno a la IA y para garantizar el cumplimiento de las normas \u00e9ticas y jur\u00eddicas a nivel de la UE. \u202fObtenga m\u00e1s informaci\u00f3n sobre los fascinantes aspectos legales de OPTIMA en la siguiente serie de videos cortos.  <\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; No eliminar\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/lmW0C8Z5nDE\u00bb _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbDatos personales y no personales\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb header_2_line_height=\u00bb1.3em\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Diferencia entre datos personales y datos no personales <\/h2>\n<p>El v\u00eddeo explica la diferencia entre datos personales y no personales, ya que la distinci\u00f3n influye en la clasificaci\u00f3n jur\u00eddica, por ejemplo, en la aplicaci\u00f3n del RGPD. OPTIMA utiliza datos personales y despersonalizados. \u00bfQu\u00e9 significa eso? Descubre m\u00e1s en nuestro v\u00eddeo.   <\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; No eliminar\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/c9S74j9dwHA\u00bb _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbDatos sint\u00e9ticos\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb header_2_line_height=\u00bb1.3em\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Explorando los datos sint\u00e9ticos: redefiniendo la privacidad en la innovaci\u00f3n <\/h2>\n<p>El v\u00eddeo explica qu\u00e9 son los datos sint\u00e9ticos y c\u00f3mo podr\u00edan ser beneficiosos para la investigaci\u00f3n m\u00e9dica, incluyendo la opci\u00f3n del proyecto OPTIMA de generar datos sint\u00e9ticos, permitiendo la innovaci\u00f3n y la toma de decisiones sin comprometer la privacidad.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; No eliminar\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/5mgRSip58SY\u00bb _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbLa IA en la sanidad\u00bb _builder_version=\u00bb4.24.3&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb header_2_line_height=\u00bb1.3em\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Inteligencia Artificial en la Salud <\/h2>\n<p>El v\u00eddeo presenta brevemente los aspectos de la IA en la asistencia sanitaria y c\u00f3mo los pacientes pueden beneficiarse de los desarrollos de OPTIMA.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; No eliminar\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/g0aAC1QpbdM\u00bb _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb3_5,2_5&#8243; admin_label=\u00bbSesgo injusto\u00bb _builder_version=\u00bb4.23.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb||||false|false\u00bb custom_margin_tablet=\u00bb||60px||false|false\u00bb custom_margin_phone=\u00bb||60px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb collapsed=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb header_2_line_height=\u00bb1.3em\u00bb header_3_line_height=\u00bb1.1em\u00bb header_4_line_height=\u00bb1.3em\u00bb custom_margin=\u00bb0px||||false|false\u00bb custom_padding=\u00bb0px||||false|false\u00bb header_3_line_height_tablet=\u00bb1.1em\u00bb header_3_line_height_phone=\u00bb1.1em\u00bb header_3_line_height_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Sesgo injusto en la inteligencia artificial<\/h2>\n<p>El v\u00eddeo describe qu\u00e9 es el sesgo injusto y qu\u00e9 papel desempe\u00f1a en el desarrollo y la interacci\u00f3n con los sistemas de IA.<\/p>\n<p>[\/et_pb_text][et_pb_code admin_label=\u00bbAdmin &#8211; No eliminar\u00bb module_class=\u00bbpostcontent  \u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<div class=\"currentpostcategory\">all<\/div>\n<p>[\/et_pb_code][\/et_pb_column][et_pb_column type=\u00bb2_5&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/Rtpvr3_n_hY\u00bb _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb4px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbIntegration Publications\u00bb _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb da_disable_devices=\u00bboff|off|off\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb da_is_popup=\u00bboff\u00bb da_exit_intent=\u00bboff\u00bb da_has_close=\u00bbon\u00bb da_alt_close=\u00bboff\u00bb da_dark_close=\u00bboff\u00bb da_not_modal=\u00bbon\u00bb da_is_singular=\u00bboff\u00bb da_with_loader=\u00bboff\u00bb da_has_shadow=\u00bbon\u00bb][et_pb_row _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb header_2_font=\u00bb|700|||||||\u00bb header_2_text_align=\u00bbcenter\u00bb header_2_line_height=\u00bb120%\u00bb header_4_line_height=\u00bb1.3em\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2 style=\"text-align: left;\">Entregables Public\u00f3s<\/h2>\n<p style=\"text-align: left;\">A continuaci\u00f3n encontrar\u00e1 enlaces a todos los entregables public\u00f3s del consorcio OPTIMA:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D2.2_Initial-report-on-the-legal-and-ethical-framework-of-the-project.pdf\">D2.2 Initial report on the legal and ethical framework of the project<\/a><\/li>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D3.1_A-report-on-identified-research-questions-and-guidelines-including-process-of-selection-and-prioritisation.pdf\">D3.1 A report on identified research questions and guidelines, including process of selection and prioritisation<\/a><\/li>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D5.1_User-personas-and-champions-identified.pdf\">D5.1 User personas &amp; champions identified<\/a><\/li>\n<li><a href=\"https:\/\/www.optima-oncology.eu\/wp-content\/uploads\/OPTIMA_D8.3_Report-on-project-specific-website-and-social-media-platforms.pdf\">D8.3 Report on project-specific website and social media platforms<\/a><\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.23.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.24.3&#8243; _module_preset=\u00bbdefault\u00bb text_orientation=\u00bbcenter\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<h2 style=\"text-align: left;\">Publicaciones<\/h2>\n<p style=\"text-align: left;\">George Corby, Nicola L. Barclay, Eng Hooi Tan, Edward Burn, Antonella Delmestri, Talita Duarte-Salles, Asieh Golozar, Wai Yi Man, Ilona Tietzova, Daniel Prieto-Alhambra. Danielle Newby. <strong>Incidence, prevalence, and survival of lung cancer in the United Kingdom from 2000\u20132021: a population-based cohort study<\/strong>. Translational Lung Cancer Research. Vol 13, No 9 (September 30, 2024)\u00a0<a href=\"https:\/\/tlcr.amegroups.org\/article\/view\/90838\/html\">doi: 10.21037\/tlcr-24-241<\/a><\/p>\n<p style=\"text-align: left;\">Barclay Nicola L., Pineda Moncus\u00ed Marta, J\u00f6dicke Annika M., Prieto-Alhambra Daniel, Ravent\u00f3s Berta, Newby Danielle, Delmestri Antonella, Man Wai Yi, Chen Xihang, Catal\u00e0 Marti. <strong>The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. <\/strong>Frontiers in Oncology. 2024, vol. 14, <a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1370862\/full\">DOI=10.3389\/fonc.2024.1370862<\/a><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">Barclay Nicola L., Pineda <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Moncus\u00ed<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> Marta, J\u00f6dicke Annika M., Prieto-Alhambra Daniel, <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Ravent\u00f3s<\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> Berta, <\/span><span class=\"SCXP33389798 BCX8\">Newby<\/span><span class=\"NormalTextRun SCXP33389798 BCX8\"> Danielle, <\/span><span class=\"SCXP33389798 BCX8\">Delmestri<\/span><span class=\"NormalTextRun SCXP33389798 BCX8\"> Antonella, <\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">Man Wai Yi, Chen <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Xihang<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">, <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Catal\u00e0<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> Marti. <\/span><\/span><strong><span class=\"TextRun SCXP33389798 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, <\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">colorectal, lung and prostate cancer in the UK: a population-based cohort study. <\/span><\/span><\/strong><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Frontiers<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\"> in <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP33389798 BCX8\">Oncology<\/span><\/span><span class=\"TextRun SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">. 2024, vol. 14, <\/span><\/span><a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2024.1370862\/full\"><span class=\"TextRun SCXP33389798 BCX8\" lang=\"IT-IT\" xml:lang=\"IT-IT\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP33389798 BCX8\">DOI=10.3389\/fonc.2024.1370862<\/span><\/span><\/a><\/p>\n<p style=\"text-align: left;\"><span class=\"EOP SCXP33389798 BCX8\"><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">E. <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Lavrova<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> et al., \u00ab<strong>UR-<\/strong><\/span><\/span><strong><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">CarA<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">-Net: A <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Cascaded<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> Framework <\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">With<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Uncertainty<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Regularization<\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"> <span class=\"SCXP18682443 BCX8\">for<\/span> <\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Automated<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> Segmentation <\/span><\/span><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">of<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Carotid<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">Arteries<\/span><\/span><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"> on <\/span><\/span><\/strong><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\"><strong>Black Blood MR Images<\/strong>,\u00bb in <\/span><span class=\"ContextualSpellingAndGrammarErrorZoomed SCXP18682443 BCX8\">IEEE Access<\/span><span class=\"NormalTextRun SCXP18682443 BCX8\">, vol. 11, pp. 26637-26651, 2023, <\/span><\/span><a href=\"https:\/\/ieeexplore.ieee.org\/document\/10073528\"><span class=\"TextRun SpellingErrorZoomed SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"SCXP18682443 BCX8\">doi<\/span><\/span><\/a><span class=\"TextRun SCXP18682443 BCX8\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun SCXP18682443 BCX8\">: 10.1109\/ACCESS.2023.3258408.<\/span><\/span><br \/><\/span><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Salahuddin<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">, Z.; Chen, Y.; Zhong, X.; Woodruff, H.C.; Rad, N.M.; Mali, S.A.; <\/span><span class=\"BCX8 SCXP179426825\">Lambin<\/span><span class=\"NormalTextRun  BCX8 SCXP179426825\">, P. <\/span><\/span><strong><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">From<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> Head and Neck <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Tumour<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> and <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Lymph<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> Node <\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">Segmentation <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">to<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> Survival <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Prediction<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"> on PET\/CT: An End-<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">to<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">-End Framework <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Featuring<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Uncertainty<\/span><\/span><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\">, Fairness, and Multi-Region Multi-Modal <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP179426825\">Radiomics<\/span><\/span><\/strong><span class=\"TextRun  BCX8 SCXP179426825\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP179426825\"><strong>.<\/strong> Cancers 2023, 15, 1932. <a href=\"https:\/\/doi.org\/10.3390\/cancers15071932\">https:\/\/doi.org\/10.3390\/cancers15071932<\/a><\/span><\/span><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP175012020\">N\u2019Dow<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\"> J., Smith E.J., <\/span><span class=\"BCX8 SCXP175012020\">Polychronopoulos<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> K., Cannon A., <\/span><span class=\"BCX8 SCXP175012020\">Roobol<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> M. J., <\/span><span class=\"BCX8 SCXP175012020\">Auweter<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> S., Thomas M., Kremer A., De <\/span><span class=\"BCX8 SCXP175012020\">Meulder<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> B., <\/span><span class=\"BCX8 SCXP175012020\">Dellamonica<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> D., <\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">Prieto-Alhambra D., <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP175012020\">Asiimwe<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\"> A., <\/span><span class=\"BCX8 SCXP175012020\">Bussmann<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> M., Xiang J., <\/span><span class=\"BCX8 SCXP175012020\">Torremante<\/span><span class=\"NormalTextRun  BCX8 SCXP175012020\"> P., Keller S., Kube F., Kr\u00fcger H., OPTIMA <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP175012020\">Consortium<\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">. (2022) <\/span><\/span><strong><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">OPTIMA: <\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">Improve care for patients with prostate, breast, and lung cancer through artificial intelligence<\/span><\/span><\/strong> <span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">ESMO <\/span><\/span><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"EN-US\" xml:lang=\"EN-US\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">#917P <\/span><\/span><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">e-Posters &#8211; ESMO <\/span><\/span><\/a><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">Congress<\/span><\/span><\/a><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\"> 2022 <\/span><\/span><\/a><a class=\"Hyperlink  BCX8 SCXP175012020\" href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal_2\/presentation\/list?q=917p\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"TextRun  BCX8 SCXP175012020\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP175012020\">(ctimeetingtech.com)<\/span><\/span><\/a><\/p>\n<p style=\"text-align: left;\"><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Refaee<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, T., <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Bondue<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, B., Van <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Simaeys<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, G., Wu, G., Yan, C., Woodruff, H. C., Goldman, S., &amp; <\/span><span class=\"BCX8 SCXP267898365\">Lambin<\/span><span class=\"NormalTextRun  BCX8 SCXP267898365\">, P. (2022). <strong>A <\/strong><\/span><\/span><strong><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Handcrafted<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Radiomics-<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Based<\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> Model <\/span><span class=\"BCX8 SCXP267898365\">for<\/span> <\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">the<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> Diagnosis <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">of<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Usual<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> Interstitial <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Pneumonia<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\"> in <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Patients<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">with<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Idiopathic<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Pulmonary<\/span><\/span> <span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Fibrosis<\/span><\/span><\/strong><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">. J Pers <\/span><\/span><span class=\"TextRun SpellingErrorZoomed  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"BCX8 SCXP267898365\">Med<\/span><\/span><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">, 12(3). <\/span><\/span><a href=\"https:\/\/doi.org\/10.3390\/jpm12030373\"><span class=\"TextRun  BCX8 SCXP267898365\" lang=\"DE-DE\" xml:lang=\"DE-DE\" data-usefontface=\"false\" data-contrast=\"none\"><span class=\"NormalTextRun  BCX8 SCXP267898365\">https:\/\/doi.org\/10.3390\/jpm12030373<\/span><\/span><\/a><\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Li, R., Sharma, V., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Thangamani<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, S., &amp; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Yakimovich<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, A. (2022). <strong>Open-Source Biomedical Image Analysis Models: A Meta-Analysis and <\/strong><\/span><strong>Continuous<\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong> Survey.<\/strong> Front <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Bioinform<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, 2, 912809. <a href=\"https:\/\/doi.org\/10.3389\/fbinf.2022.912809\">https:\/\/doi.org\/10.3389\/fbinf.2022.912809<\/a>\u00a0 <\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Halilaj<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> I, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oberije<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> C, Chatterjee A, van <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Wijk<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Y, Rad NM, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Galganebanduge<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> P, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Lavrova<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> E, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Primakov<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> S, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Widaatalla<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Y, Wind A, Lambin P. <strong>Open <\/strong><\/span><strong>Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology. <\/strong><span data-usefontface=\"false\" data-contrast=\"none\">Biomedicines<\/span><span data-usefontface=\"false\" data-contrast=\"none\">. 2022 <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oct<\/span> <span data-usefontface=\"false\" data-contrast=\"none\">23;10(11):2679. <\/span><a href=\"https:\/\/www.mdpi.com\/2227-9059\/10\/11\/2679\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">: 10.3390\/biomedicines10112679. PMID: 36359199; PMCID: PMC9687260.<\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Refaee<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, T.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Salahuddin<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, Z.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Widaatalla<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, Y.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Primakov<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, S.; Woodruff, H.C.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Hustinx<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, R.; <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Mottaghy<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, F.M.; Ibrahim, A.; Lambin, P. <strong>CT <\/strong><\/span><strong>Reconstruction Kernels and the Effect of Pre- and Post-Processing on the Reproducibility of Handcrafted Radiomic<\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong> Features<\/strong>. J. Pers. Med. <\/span><span data-usefontface=\"false\" data-contrast=\"none\">2022, 12, 553. <a href=\"https:\/\/doi.org\/10.3390\/jpm12040553\">https:\/\/doi.org\/10.3390\/jpm12040553<\/a><\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Refaee<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, T., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Salahuddin<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, Z., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Frix<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, A.-N., Yan, C., Wu, G., Woodruff, H. C., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Gietema<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, H., Meunier, P., Louis, R., <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Guiot<\/span><span data-usefontface=\"false\" data-contrast=\"none\">, J., &amp; Lambin, P. (2022). <\/span><strong>Diagnosis of Idiopathic Pulmonary Fibrosis in High-Resolution Computed Tomography Scans Using a Combination of Handcrafted Radiomics <\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong>and Deep Learning<\/strong> [Original Research]. Frontiers in Medicine, 9. <a href=\"https:\/\/doi.org\/10.3389\/fmed.2022.915243\">https:\/\/doi.org\/10.3389\/fmed.2022.915243 <\/a><\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Keek<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> SA, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Beuque<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> M, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Primakov<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> S, Woodruff HC, Chatterjee A, van <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Timmeren<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> JE, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Valli\u00e8res<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> M, Hendriks LEL, Kraft J, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Andratschke<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> N, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Braunstein SE, Morin O, Lambin P. <\/span><strong>Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics<\/strong><span data-usefontface=\"false\" data-contrast=\"none\">. Front <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oncol<\/span><span data-usefontface=\"false\" data-contrast=\"none\">. 2022 Jul 13;12:920393. <\/span><a href=\"https:\/\/www.frontiersin.org\/journals\/oncology\/articles\/10.3389\/fonc.2022.920393\/full\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">:10.3389\/fonc.2022.920393. PMID: 35912214; PMCID: PMC9326101.<\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Ibrahim A, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Barufaldi<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> B, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Refaee<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> T, Silva <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Filho<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> TM, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Acciavatti<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> RJ, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Salahuddin<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Z, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Hustinx<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> R, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Mottaghy<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> FM, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Maidment<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> ADA, Lambin P. <\/span><strong>MaasPenn Radiomics Reproducibility Score: A Novel Quantitative Measure for Evaluating the Reproducibility of CT-Based Handcrafted Radiomic <\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong>Features.<\/strong> Cancers (Basel). 2022 Mar 22;14(7):1599. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35406372\/\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">:10.3390\/cancers14071599. PMID: 35406372; PMCID: PMC8997100.<\/span>\u200b<\/p>\n<p style=\"text-align: left;\" data-ccp-props=\"{&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559683&quot;:0,&quot;335559685&quot;:0,&quot;335559731&quot;:0,&quot;335559737&quot;:0,&quot;335562764&quot;:2,&quot;335562765&quot;:0.9,&quot;335562766&quot;:4,&quot;335562767&quot;:10,&quot;335562768&quot;:4,&quot;335562769&quot;:0}\"><span data-usefontface=\"false\" data-contrast=\"none\">Griesinger F, Curigliano G, Thomas M, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Subbiah<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> V, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Baik<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> CS, Tan DSW, Lee DH, Misch D, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Garralda<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> E, Kim DW, van der <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Wekken<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> AJ, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Gainor<\/span> <span data-usefontface=\"false\" data-contrast=\"none\">JF, Paz-Ares L, Liu SV, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Kalemkerian<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> GP, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Houvras<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> Y, Bowles DW, Mansfield AS, Lin JJ, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Smoljanovic<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> V, Rahman A, Kong S, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Zalutskaya<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> A, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Louie-Gao M, <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Boral<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> AL, Mazi\u00e8res J. <\/span><strong>Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial<\/strong><span data-usefontface=\"false\" data-contrast=\"none\"><strong>.<\/strong> Ann <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Oncol<\/span><span data-usefontface=\"false\" data-contrast=\"none\">. 2022 Nov;33(11):1168-1178. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35973665\/\"><span data-usefontface=\"false\" data-contrast=\"none\">doi<\/span><\/a><span data-usefontface=\"false\" data-contrast=\"none\">:10.1016\/j.annonc.2022.08.002. <\/span><span data-usefontface=\"false\" data-contrast=\"none\">Epub<\/span><span data-usefontface=\"false\" data-contrast=\"none\"> 2022 Aug 13. <\/span><span data-usefontface=\"false\" data-contrast=\"none\">PMID: 35973665.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aqu\u00ed puedes encontrar las fichas t\u00e9cnicas, publicaciones y la biblioteca de v\u00eddeos m\u00e1s importantes sobre el proyecto OPTIMA.<\/p>\n","protected":false},"author":1,"featured_media":4251,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-8087","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/pages\/8087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/comments?post=8087"}],"version-history":[{"count":13,"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/pages\/8087\/revisions"}],"predecessor-version":[{"id":8729,"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/pages\/8087\/revisions\/8729"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/media\/4251"}],"wp:attachment":[{"href":"https:\/\/www.optima-oncology.eu\/es\/wp-json\/wp\/v2\/media?parent=8087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}